2010 Volume 9 Issue 12 Pages 873-918
This paper analyzes the pharmaceutical innovation processes behind Takeda Pharmaceutical’s Rozerem and explores relevant success factors. Although much of the previous research deals with the search stage of the upstream innovation process, this paper focuses on downstream clinical trials and regulatory applications (NDA), marketing, and retail stages. Amidst global competition in the development of new medications, this case study reveals management focus on the developmental time period, such as the “parallel research approach,” as the main success factor in Takeda’s development.